Quantitative Total Extensible Imaging (QTxI) vs Viz Subdural+
AI Verdict
Choose Quantitative Total Extensible Imaging (QTxI) if…
Choose Quantitative Total Extensible Imaging (QTxI) if your clinical practice requires comprehensive, quantitative analysis of DICOM CT and PET images for detailed treatment monitoring, particularly in oncology. This tool is ideal for identifying, contouring, and statistically analyzing Regions of Interest across multiple modalities to track disease progression and generate automated reports.
View Quantitative Total Extensible Imaging (QTxI) →Choose Viz Subdural+ if…
Choose Viz Subdural+ if your priority is the rapid, AI-powered detection, labeling, and quantification of subdural hemorrhages on non-contrast CT scans to streamline diagnosis and care coordination for neurovascular conditions. This tool is specifically designed to automate the identification and measurement of acute and chronic subdural collections, including volume, thickness, and midline shift.
View Viz Subdural+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Quantitative Total Extensible Imaging (QTxI) | Viz Subdural+ |
|---|---|---|
| Pricing | Contact for pricing | Subscription model |
| Deployment | Cloud-based | Cloud-native platform, available as part of the Viz.ai One platform. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz Subdural+Viz Subdural+ emphasizes 'streamlined workflow' and 'auto-detection' for subdural hemorrhages, aiming to reduce manual effort and increase efficiency for healthcare professionals. Its integration into the Viz.ai One platform with real-time alerts and mobile/desktop access suggests a user-friendly experience focused on accelerating diagnosis and care. QTxI, while powerful for quantitative analysis in oncology, presents a more comprehensive feature set that might imply a steeper learning curve.
Clinical Value
TieBoth tools offer significant clinical value in their specialized domains. QTxI provides advanced quantitative analysis for oncology treatment monitoring, with studies demonstrating superior prognostication over standard methods and a new Category III CPT code for its unique analysis. Viz Subdural+ offers rapid, automated detection and quantification of subdural hemorrhages, validated by clinical studies for high accuracy and impact on timely intervention and patient outcomes. Their distinct focuses prevent a clear winner in overall clinical impact.
Pricing & Value
Viz Subdural+Viz Subdural+ operates on a 'Subscription model' for 'Enterprise (Hospital/Health System)' and has achieved CMS reimbursement for its AI solutions, indicating a recognized value proposition and a clearer path to financial integration for hospitals. QTxI's pricing is not publicly available, requiring direct contact with the vendor for custom pricing, which offers less transparency regarding its value proposition.
Enterprise Readiness
Viz Subdural+Viz Subdural+ demonstrates superior enterprise readiness as it is part of the widely deployed Viz.ai One platform, which is integrated into 2,000 hospitals and offers extensive integrations with EHRs and PACS. Beyond being cloud-based, HIPAA-compliant, and FDA-cleared like QTxI, Viz.ai also provides comprehensive security and compliance certifications (SOC 2 Type II, ISO, GDPR) through its Trust Center.
Innovation
Viz Subdural+Viz Subdural+ is part of Viz.ai's broader 'AI-powered disease detection and intelligent care coordination' platform, which has received multiple prestigious Edison Awards and the Prix Galien USA Award for Best Digital Health Solution. This recognition highlights its impactful approach to integrating AI across the entire care pathway for acute conditions. While QTxI offers innovative quantitative analysis in oncology and has received innovation grants, Viz.ai's consistent accolades and focus on 'agentic infrastructure' suggest a more recognized and comprehensive innovation strategy.
Support & Docs
Viz Subdural+Viz.ai offers comprehensive and easily accessible support, including 24/7 urgent phone support, email, in-app support, a dedicated Help Center, user guides, and a training academy (Viz Academy). In contrast, specific support and documentation information for AIQ Solutions' QTxI is scarce online, often leading to resources for other companies with similar names, making it difficult to assess their offerings.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Quantitative Total Extensible Imaging (QTxI) | Viz Subdural+ |
|---|---|---|
| Tool Name | Quantitative Total Extensible Imaging (QTxI) | Viz Subdural+ |
| Company | AIQ Solutions | Viz.ai |
| Tagline | Optimizing late-stage cancer care with technology-enabled service. | AI-powered disease detection and intelligent care coordination to accelerate diagnosis and treatment. |
| Primary Focus | Evaluation and management of digital medical images (DICOM CT and PET) for quantitative analysis of Regions of Interest, particularly in oncology. | Automated detection, labeling, and quantification of subdural hemorrhages on non-contrast CT scans. |
| Key Modalities | DICOM CT and PET | Non-contrast head CT images |
| Specialties | Nuclear Medicine, Oncology, Radiology | Neurology, Neurosurgery, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Quantitative Total Extensible Imaging (QTxI) and Viz Subdural+.